Business Description
Optus Pharmaceutical Co Ltd
ISIN : KR7131030009
Compare
Compare
Traded in other countries / regions
131030.Korea IPO Date
2010-12-03Description
Optus Pharmaceutical Co Ltd is engaged in the manufacturing of finished medicaments.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 34.35 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.11 | |||||
| Interest Coverage | 74.72 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 5.92 | |||||
| Beneish M-Score | -2.11 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.4 | |||||
| 3-Year EBITDA Growth Rate | -4.3 | |||||
| 3-Year EPS without NRI Growth Rate | -11.2 | |||||
| 3-Year FCF Growth Rate | -5.7 | |||||
| 3-Year Book Growth Rate | 5.9 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.26 | |||||
| 9-Day RSI | 50.59 | |||||
| 14-Day RSI | 49.44 | |||||
| 6-1 Month Momentum % | 18.87 | |||||
| 12-1 Month Momentum % | 6.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.58 | |||||
| Quick Ratio | 5.53 | |||||
| Cash Ratio | 4.79 | |||||
| Days Inventory | 145.6 | |||||
| Days Sales Outstanding | 42.6 | |||||
| Days Payable | 18.99 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.64 | |||||
| Dividend Payout Ratio | 0.16 | |||||
| Forward Dividend Yield % | 1.64 | |||||
| 5-Year Yield-on-Cost % | 1.63 | |||||
| 3-Year Average Share Buyback Ratio | 1.7 | |||||
| Shareholder Yield % | 2.18 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 57 | |||||
| Operating Margin % | 11.88 | |||||
| Net Margin % | 14.98 | |||||
| FCF Margin % | 3.96 | |||||
| ROE % | 8.49 | |||||
| ROA % | 7.67 | |||||
| ROIC % | 9.47 | |||||
| ROC (Joel Greenblatt) % | 24.77 | |||||
| ROCE % | 10.16 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 8.36 | |||||
| PE Ratio without NRI | 10.02 | |||||
| Shiller PE Ratio | 7.98 | |||||
| Price-to-Owner-Earnings | 12.96 | |||||
| PS Ratio | 1.25 | |||||
| PB Ratio | 0.69 | |||||
| Price-to-Tangible-Book | 0.72 | |||||
| Price-to-Free-Cash-Flow | 31.35 | |||||
| Price-to-Operating-Cash-Flow | 8.07 | |||||
| EV-to-EBIT | 2.23 | |||||
| EV-to-EBITDA | 1.72 | |||||
| EV-to-Revenue | 0.41 | |||||
| EV-to-FCF | 10.24 | |||||
| Price-to-Projected-FCF | 0.56 | |||||
| Price-to-Median-PS-Value | 0.46 | |||||
| Price-to-Graham-Number | 0.57 | |||||
| Price-to-Net-Current-Asset-Value | 1.26 | |||||
| Price-to-Net-Cash | 1.88 | |||||
| Earnings Yield (Greenblatt) % | 44.84 | |||||
| FCF Yield % | 3.16 | |||||
| Forward Rate of Return (Yacktman) % | -0.4 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Optus Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 74,206.132 | ||
| EPS (TTM) (â‚©) | 730 | ||
| Beta | 0.45 | ||
| Volatility % | 36.04 | ||
| 14-Day RSI | 49.44 | ||
| 14-Day ATR (â‚©) | 195.260761 | ||
| 20-Day SMA (â‚©) | 6099.5 | ||
| 12-1 Month Momentum % | 6.6 | ||
| 52-Week Range (â‚©) | 4465 - 9550 | ||
| Shares Outstanding (Mil) | 15.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Optus Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Optus Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Optus Pharmaceutical Co Ltd Frequently Asked Questions
What is Optus Pharmaceutical Co Ltd(XKRX:131030)'s stock price today?
The current price of XKRX:131030 is â‚©6100.00. The 52 week high of XKRX:131030 is â‚©9550.00 and 52 week low is â‚©4465.00.
When is next earnings date of Optus Pharmaceutical Co Ltd(XKRX:131030)?
The next earnings date of Optus Pharmaceutical Co Ltd(XKRX:131030) is .
Does Optus Pharmaceutical Co Ltd(XKRX:131030) pay dividends? If so, how much?
The Dividend Yield %  of Optus Pharmaceutical Co Ltd(XKRX:131030) is 1.64% (As of Today), Highest Dividend Payout Ratio of Optus Pharmaceutical Co Ltd(XKRX:131030) was 0.33. The lowest was 0.11. And the median was 0.15. The  Forward Dividend Yield % of Optus Pharmaceutical Co Ltd(XKRX:131030) is 1.64%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers